France's pharmacists hit back at competition

27 April 2008

French pharmacists have launched protests against the campaign by one of the country's leading retailers, the Leclerc group (Marketletter April 14), to allow non-reimbursed prescription drugs to be sold at discount rates outside pharmacies. The retail giant claims it would offer 25% rebates to customers if the French government opened up the market. In the southern departement of l'Herault, a local pharmacists' union (CSPH) has decided to sell groceries, such as tinned peas or washing powder, for one month. The idea is to drive home the message that drugs must not be considered equal to other retail products, the group explained.

In a separate development, the TF1 television network reports that a pharmacy group, Univers Pharmacie, has applied for a legal order to demand that Leclerc withdraws its advertising campaign, to promote the case for deregulation. The plaintiff is requesting damages of 20,000 euros (about $39,700) per day that the low-cost retailer fails to comply.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight